UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overexpression of the microtubule-binding protein CLIP-170 induces a +TIP network superstructure consistent with a biomolecular condensate

PloS one, 2021-12, Vol.16 (12), p.e0260401-e0260401

2021

Volltextzugriff (PDF)

The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea

Canadian journal of gastroenterology & hepatology, 2024, Vol.2024, p.5667986

2024

Volltextzugriff (PDF)

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

JHEP reports, 2024-02, Vol.6 (2), p.100915, Article 100915

2024

Volltextzugriff (PDF)

Personal Protective Equipment and Donning and Doffing Techniques in the Cardiac Catheterization Laboratory During the COVID-19 Pandemic: Insights From an Internet Search for Protocols

Frontiers in cardiovascular medicine, 2021-05, Vol.8, p.652298-652298

2021

Volltextzugriff (PDF)

Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes

Endocrinology, diabetes & metabolism, 2020-01, Vol.3 (1), p.e00107-n/a

2020

Volltextzugriff (PDF)

Continuity in Medications Used by Adults with Diabetes in the United States, 2005-2019

Annals of family medicine, 2023-01, Vol.21 (S1)

2023

Volltextzugriff (PDF)

641: THE GROWING BURDEN OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1133-S-1134

2022

Volltextzugriff (PDF)

1311-P: Machine Learning (ML) Application to Predict Patient Risk of Nonadherence in Type 2 Diabetes Management Using U.S. Claims Databases

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Trends in Receipt of American Diabetes Association Guideline-Recommended Care Among U.S. Adults With Diabetes: NHANES 2005-2018

Diabetes care, 2021-06, Vol.44 (6), p.1300-1308

2021

Volltextzugriff (PDF)

Long-Term Incidence of Liver Disease in the Diabetes Population in Israel

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Risk of Nonalcoholic Fatty Liver Disease (NAFLD)-Related Liver Complications in the Diabetic Population in Israel

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

S1394 NASHDetection: A Natural Language Processing Method for Identifying Patients With Non-alcoholic Steatohepatitis Using Clinical Notes

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1067-S1067

2023

Volltextzugriff (PDF)

S1395 Uncontrolled Diabetes and Hypertension Are Associated With the Risk of New-Onset Cirrhosis in Patients With Nonalcoholic Steatohepatitis

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1067-S1067

2023

Volltextzugriff (PDF)

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Hepatology (Baltimore, Md.), 2024-08

2024

Volltextzugriff (PDF)

Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018

Annals of hepatology, 2024-01, Vol.29 (1), p.101154-101154, Article 101154

2024

Volltextzugriff (PDF)

S1356 Correlation Between Systemic Inflammatory Markers and Evidence of Metastatic Disease in Patients With Hepatocellular Carcinoma

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e974-e975

2022

Volltextzugriff (PDF)

Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers—a cohort study in 1,260 patients

JOURNAL OF HEPATOLOGY, 2023, Vol.78, p.S653

2023

Volltextzugriff (PDF)

Long-term liver-related outcomes in 1,260 patients with non-cirrhotic NAFLD

JOURNAL OF HEPATOLOGY, 2023, Vol.78, p.S650-S651

2023

Volltextzugriff (PDF)

2431-PUB: Distance from Glycemic Target at the Time of Intensification in Patients with Type 2 Diabetes (T2D) Failing Metformin Dual Therapy in the United States

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1144-P: Distribution of Prescribed Dose During the First Year of Metformin Monotherapy in the U.S

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1495-P: Distance to Glycemic Target of Patients (Pts) with Type 2 Diabetes (T2D) and Established Cardiovascular Disease (eCVD) and/or Chronic Kidney Disease (CKD) Failing Metformin Monotherapy in the U.S

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

2352-PUB: Level of Glycemic Control in Type 2 Diabetes (T2D) Patients with Established Cardiovascular Disease (eCVD) or Chronic Kidney Disease (CKD) Prescribed an SGLT2i

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1496-P: Clinical Inertia in Relation to Sociodemographic Factors among Patients with Type 2 Diabetes (T2D) in the United States

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

SAT-397 - Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers—a cohort study in 1,260 patients

Journal of hepatology, 2023-06, Vol.78, p.S653-S653

2023

Volltextzugriff (PDF)

THU-423 - Long-term prognosis of patients with non-alcoholic fatty liver disease: a retrospective cohort study to understand the impact of surrogate disease end points on long-term outcomes in South Korea

Journal of hepatology, 2023-06, Vol.78, p.S610-S610

2023

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(105)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Overexpression of the microtubule-binding protein CLIP-170 induces a +TIP network superstructure consistent with a biomolecular condensate

The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

Personal Protective Equipment and Donning and Doffing Techniques in the Cardiac Catheterization Laboratory During the COVID-19 Pandemic: Insights From an Internet Search for Protocols

Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes

Continuity in Medications Used by Adults with Diabetes in the United States, 2005-2019

641: THE GROWING BURDEN OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES

1311-P: Machine Learning (ML) Application to Predict Patient Risk of Nonadherence in Type 2 Diabetes Management Using U.S. Claims Databases

Trends in Receipt of American Diabetes Association Guideline-Recommended Care Among U.S. Adults With Diabetes: NHANES 2005-2018

Long-Term Incidence of Liver Disease in the Diabetes Population in Israel

Risk of Nonalcoholic Fatty Liver Disease (NAFLD)-Related Liver Complications in the Diabetic Population in Israel

S1394 NASHDetection: A Natural Language Processing Method for Identifying Patients With Non-alcoholic Steatohepatitis Using Clinical Notes

S1395 Uncontrolled Diabetes and Hypertension Are Associated With the Risk of New-Onset Cirrhosis in Patients With Nonalcoholic Steatohepatitis

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018

S1356 Correlation Between Systemic Inflammatory Markers and Evidence of Metastatic Disease in Patients With Hepatocellular Carcinoma

Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers—a cohort study in 1,260 patients

Long-term liver-related outcomes in 1,260 patients with non-cirrhotic NAFLD

2431-PUB: Distance from Glycemic Target at the Time of Intensification in Patients with Type 2 Diabetes (T2D) Failing Metformin Dual Therapy in the United States

1144-P: Distribution of Prescribed Dose During the First Year of Metformin Monotherapy in the U.S

1495-P: Distance to Glycemic Target of Patients (Pts) with Type 2 Diabetes (T2D) and Established Cardiovascular Disease (eCVD) and/or Chronic Kidney Disease (CKD) Failing Metformin Monotherapy in the U.S

2352-PUB: Level of Glycemic Control in Type 2 Diabetes (T2D) Patients with Established Cardiovascular Disease (eCVD) or Chronic Kidney Disease (CKD) Prescribed an SGLT2i

1496-P: Clinical Inertia in Relation to Sociodemographic Factors among Patients with Type 2 Diabetes (T2D) in the United States

SAT-397 - Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers—a cohort study in 1,260 patients

THU-423 - Long-term prognosis of patients with non-alcoholic fatty liver disease: a retrospective cohort study to understand the impact of surrogate disease end points on long-term outcomes in South Korea

Suchergebnisse filtern